Pei, G.; Buijze, H.; Liu, H.; Moura-Alves, P.; Goosmann, C.; Brinkmann, V.; Kawabe, H.; Dorhoi, A.; Kaufmann, S. H. E.: The E3 ubiquitin ligase NEDD4 enhances killing of membrane-perturbing intracellular bacteria by promoting autophagy. Autophagy 13 (12), S. 2041 - 2055 (2017)

Platteel, A. C.M.; Nieuwenhuizen, N. E.; Domaszewska, T.; Schürer, S.; Zedler, U.; Brinkmann, V.; Sijts, A. J. A. M.; Kaufmann, S. H. E.: Efficacy Testing of H56 cDNA Tattoo Immunization against Tuberculosis in a Mouse Model. Frontiers in immunology 8, 1744 (2017)

Haks, M. C.; Bottazzi, B.; Cecchinato, V.; Gregorio, C. D.; Giudice, G. D.; Kaufmann, S. H. E.; Lanzavecchia, A.; Lewis, D. J. M.; Maertzdorf, J.; Mantovani, A. et al.; Sallusto, F.; Sironi, M.; Uguccioni, M.; Ottenhoff, T. H. M.: Molecular Signatures of Immunity and Immunogenicity in Infection and Vaccination. Frontiers in immunology 8, 1563 (2017)

Herzmann, C.; Ernst, M.; Lange, C.; Stenger, S.; Kaufmann, S. H. E.; Reiling, N.; Schaberg, T.; van der Merwe, L.; Maertzdorf, J.: Pulmonary immune responses to Mycobacterium tuberculosis in exposed individuals. PLoS One 12 (11), e0187882 (2017)

Beigier-Bompadre, M.; Montagna, G. N.; Kühl, A. A.; Lozza, L.; Weiner, J.; Kupz, A.; Vogelzang, A.; Mollenkopf, H.-J.; Löwe, D.; Bandermann, S. et al.; Dorhoi, A.; Brinkmann, V.; Matuschewski, K.; Kaufmann, S. H. E.: Mycobacterium tuberculosis infection modulates adipose tissue biology. PLoS Pathogens 13 (10), e1006676 (2017)

Kaufmann, S. H. E.; Dockrell, H. M.; Drager, N.; Ho, M. M.; McShane, H.; Neyrolles, O.; Ottenhoff, T. H. M.; Patel, B.; Roordink, D.; Spertini, F. et al.; Stenger, S.; Thole, J.; Verreck, F. A. W.; Williams, A.; TBVA2020 Consortium: TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development. Frontiers in immunology 8 (Issue OCT), 1203 (2017)

Domaszewska, T.; Scheuermann, L.; Hahnke, K.; Mollenkopf, H.; Dorhoi, A.; Kaufmann, S. H. E.; Weiner, J. 3.: Concordant and discordant gene expression patterns in mouse strains identify best-fit animal model for human tuberculosis. Scientific Reports 7 (1), 12094 (2017)

Nieuwenhuizen, N. E.; Kulkarni, P. S.; Shaligram, U.; Cotton, M. F.; Rentsch, C. A.; Eisele, B.; Grode, L.; Kaufmann, S. H. E.: The Recombinant Bacille Calmette–Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing. Frontiers in immunology 8, 1147 (2017)

Zimmermann, M.; Kogadeeva, M.; Gengenbacher, M.; McEwen, G.; Mollenkopf, H.-J.; Zamboni, N.; Kaufmann, S. H. E.; Sauer, U.: Integration of Metabolomics and Transcriptomics Reveals a Complex Diet of Mycobacterium tuberculosis during Early Macrophage Infection. mSystems 2 (4), e00057-17 (2017)

Gengenbacher, M.; Duque-Correa, M. A.; Kaiser, P.; Schuerer, S.; Lazar, D.; Zedler, U.; Reece, S. T.; Nayyar, A.; Cole, S. T.; Makarov, V. et al.; Clifton, E. B. I.; Dartois, V.; Kaufmann, S. H. E.: NOS2-deficient mice with hypoxic necrotizing lung lesions predict outcomes of tuberculosis chemotherapy in humans. Scientific Reports 7 (1), 8853 (2017)

Gengenbacher, M.; Nieuwenhuizen, N. E.; Kaufmann, S. H. E.: BCG — old workhorse, new skills. Current Opinion in Immunology 47, S. 8 - 16 (2017)

Kaufmann, S. H. E.; Weiner, J. 3.; Maertzdorf, J.: Accelerating tuberculosis vaccine trials with diagnostic and prognostic biomarkers. Expert Review of Vaccines 16 (8), S. 845 - 853 (2017)

Kaufmann, S. H. E.: Emil von Behring: translational medicine at the dawn of immunology. Nature Reviews Immunology 17 (6), S. 341 - 343 (2017)

Kaufmann, S. H. E.; Weiner, J.; von Reyn, C. F.: Novel approaches to tuberculosis vaccine development. International journal of infectious diseases 56, S. 263 - 267 (2017)

Weiner, J.; Kaufmann, S. H. E.: High-throughput and computational approaches for diagnostic and prognostic host tuberculosis biomarkers. International journal of infectious diseases 56, S. 258 - 262 (2017)

Kaufmann, S. H. E.: Remembering Emil von Behring: from Tetanus Treatment to Antibody Cooperation with Phagocytes. mBio 8 (1), e00117-17 (2017)

Loxton, A. G.; Knaul, J. K.; Grode, L.; Gutschmidt, A.; Meller, C.; Eisele, B.; Johnstone, H.; van der Spuy, G.; Maertzdorf, J.; Kaufmann, S. H. E. et al.; Hesseling, A. C.; Walzl, G.; Cotton, M. F.: Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa. Clinical and Vaccine Immunology 24 (2), e00439-16 (2017)

Tornack, J.; Reece, S. T.; Bauer, W. M.; Vogelzang, A.; Bandermann, S.; Zedler, U.; Stingl, G.; Kaufmann, S. H. E.; Melchers, F.: Human and Mouse Hematopoietic Stem Cells Are a Depot for Dormant Mycobacterium tuberculosis. PLoS One 12 (1), e0169119 (2017)

Kaufmann, S. H. E.: Tuberkulose: Vergessen, aber nicht besiegt. Warum? Trillium Immunologie 2017 (1), S. 24 - 28 (2017)

Olafsdottir, T. A.; Lindqvist, M.; Nookaew, I.; Andersen, P.; Maertzdorf, J.; Persson, J.; Christensen, D.; Zhang, Y.; Anderson, J.; Khoomrung, S. et al.; Sen, P.; Agger, E. M.; Coler, R.; Carter, D.; Meinke, A.; Rappuoli, R.; Kaufmann, S. H. E.; Reed, S. G.; Harandi, A. M.: Comparative Systems Analyses Reveal Molecular Signatures of Clinically tested Vaccine Adjuvants. Scientific Reports 6, 39097 (2016)